Stay updated on Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FVxSDF3853rIdQnFpobOGZyAZ7C0.uncropped.jpg&w=3840&q=75)
Latest updates to the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check40 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 7 locations, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check47 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check61 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
- Check66 days agoChange DetectedThe value of Last Update Posted (Estimated) Revision has changed from v2.9.3 to v2.9.5, indicating an update in the information provided on the webpage.SummaryDifference0.1%
- Check67 days agoChange DetectedThe value 2023-06-26 2023-06-23 Last Update Posted 2023-06-26 2023-06 Revision: v2.9.1 has recently changed to 2024-06-25 2024-06-24 Last Update Posted (Estimated) 2024-06-25 2024-06 Revision: v2.9.3. This change represents an update in the last posted date and revision version of the study record on the webpage.SummaryDifference0.5%
Stay in the know with updates to Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in NSCLC: RET, ROS1, NTRK, MET Clinical Trial page.